OntoChem GmbH, a German Life Science IT company, announced that it has assigned its drug discovery technologies and assets, including its drug discovery collaboration with Anixa Biosciences, Inc., a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, to the newly formed MolGenie GmbH, a biotech company focusing on drug discovery and development.